RxDoctor Payments Data

Cornelia Beckham, APRN

Family · Columbia, SCNPI 1598331027

Payments from drug & device makers

$1,086in general payments, 2019–2025

Across 54 payments — averaging $20.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vifor Pharma, Inc.$574
  • Mallinckrodt Hospital Products Inc.$97
  • Otsuka America Pharmaceutical, Inc.$77
  • Calliditas Therapeutics US Inc.$59
  • Amgen$54
  • Akebia Therapeutics Inc$50
  • plus $175 from 6 others

What the payments were for

  • Food & beverage$1,06998%
  • Education$172%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,086 in reported general payments places this provider in the 65th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$55,151
Medicare patients
228
Services billed
1,070

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol24$29,204
JardianceEmpagliflozin29$19,869
Sevelamer Carbonate22$2,575
Doxazosin Mesylate40$599
Nifedipine ErNifedipine11$372
Midodrine Hcl19$331
Amlodipine Besylate59$317
Hydralazine Hcl28$284
Losartan Potassium33$238
Calcitriol18$206
Atorvastatin Calcium13$171
Carvedilol28$166
Metoprolol Succinate13$159
Lisinopril18$137
Furosemide39$122

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$37$29,20424 claims
Boehringer IngelheimJardiance$22$19,86929 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,248 family providers in South Carolina.

Other family in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →